ANDAs for Certain Highly Purified Synthetic Peptide Drug Products That Refer to Listed Drugs of rDNA Origin Guidance for Industry (2021). https://www.fda.gov/regulatory-information/search-fda-guidance-documents/andas-certain-highly-purified-synthetic-peptide-drug-products-refer-listed-drugs-rdna-origin. Accessed 24 Dec 2022

Arrahman A, Kazandjian TD, Still KBM et al (2022) A combined bioassay and nanofractionation approach to investigate the anticoagulant toxins of mamba and cobra venoms and their inhibition by varespladib. Toxins (Basel) 14:736. https://doi.org/10.3390/toxins14110736

Article  PubMed  Google Scholar 

Benet A, Halseth T, Kang J et al (2021) The effects of pH and excipients on exenatide stability in solution. Pharmaceutics 13:1263. https://doi.org/10.3390/PHARMACEUTICS13081263/S1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bothe JR, Andrews A, Smith KJ et al (2019) Peptide oligomerization memory effects and their impact on the physical stability of the GLP-1 agonist liraglutide. Mol Pharm 16:2153–2161. https://doi.org/10.1021/acs.molpharmaceut.9b00106

Article  CAS  PubMed  Google Scholar 

Chan CP (2016) Forced degradation studies: current trends and future perspectives for protein-based therapeutics. Expert Rev Proteomics 13:651–658. https://doi.org/10.1080/14789450.2016.1200469

Article  CAS  PubMed  Google Scholar 

De Groot AS, Roberts BJ, Mattei A et al (2023) Immunogenicity risk assessment of synthetic peptide drugs and their impurities. Drug Discov Today 28:103714. https://doi.org/10.1016/j.drudis.2023.103714

Article  CAS  PubMed  Google Scholar 

Dong S, Gu Y, Wei G et al (2018) Determination of liraglutide in rat plasma by a selective liquid chromatography-tandem mass spectrometry method: application to a pharmacokinetics study. J Chromatogr B Analyt Technol Biomed Life Sci 1091:29–35. https://doi.org/10.1016/j.jchromb.2018.05.020

Article  CAS  PubMed  Google Scholar 

Duivelshof BL, Fekete S, Guillarme D, D’Atri V (2019) A generic workflow for the characterization of therapeutic monoclonal antibodies—application to daratumumab. Anal Bioanal Chem 411:4615–4627. https://doi.org/10.1007/s00216-018-1561-1

Article  CAS  PubMed  Google Scholar 

Duncan MW, Gibson DS (2012) Mass spectrometry for peptide and protein analysis. Encyclopedia of analytical chemistry. Wiley, Chichester

Google Scholar 

Elbrønd B, Jakobsen G, Larsen S et al (2002) Pharmacokinetics, pharmacodynamics, safety, and tolerability of a single-dose of NN2211, a long-acting glucagon-like peptide 1 derivative, in healthy male subjects. Diabetes Care 25:1398–1404. https://doi.org/10.2337/diacare.25.8.1398

Article  PubMed  Google Scholar 

Fincke A, Winter J, Bunte T, Olbrich C (2014) Thermally induced degradation pathways of three different antibody-based drug development candidates. Eur J Pharm Sci 62:148–160. https://doi.org/10.1016/j.ejps.2014.05.014

Article  CAS  PubMed  Google Scholar 

Frederiksen TM, Sønderby P, Ryberg LA et al (2015) Oligomerization of a glucagon-like peptide 1 analog: bridging experiment and simulations. Biophys J 109:1202–1213. https://doi.org/10.1016/J.BPJ.2015.07.051

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gallo M, Vanni D, Esposito S et al (2022) Oligomerization, albumin binding and catabolism of therapeutic peptides in the subcutaneous compartment: an investigation on lipidated GLP-1 analogs. J Pharm Biomed Anal 210:114566. https://doi.org/10.1016/J.JPBA.2021.114566

Article  CAS  PubMed  Google Scholar 

Goebel-Stengel M, Stengel A, Taché Y, Reeve JR (2011) The importance of using the optimal plasticware and glassware in studies involving peptides. Anal Biochem 414:38–46. https://doi.org/10.1016/J.AB.2011.02.009

Article  CAS  PubMed  PubMed Central  Google Scholar 

Grassi L, Cabrele C (2019) Susceptibility of protein therapeutics to spontaneous chemical modifications by oxidation, cyclization, and elimination reactions. Amino Acids 51:1409–1431. https://doi.org/10.1007/S00726-019-02787-2

Article  CAS  PubMed  Google Scholar 

Halley J, Chou YR, Cicchino C et al (2020) An industry perspective on forced degradation studies of biopharmaceuticals: survey outcome and recommendations. J Pharm Sci 109:6–21. https://doi.org/10.1016/J.XPHS.2019.09.018

Article  CAS  PubMed  Google Scholar 

Han X, Cheng F, Jie B et al (2021) Identification and characterization of new impurities in zopiclone tablets by LC-QTOF-MS. J Pharm Biomed Anal. https://doi.org/10.1016/j.jpba.2021.114056

Article  PubMed  Google Scholar 

Hawe A, Wiggenhorn M, van de Weert M et al (2012) Forced degradation of therapeutic proteins. J Pharm Sci 101:895–913. https://doi.org/10.1002/JPS.22812

Article  CAS  PubMed  Google Scholar 

Hinterholzer A, Stanojlovic V, Regl C et al (2021) Detecting aspartate isomerization and backbone cleavage after aspartate in intact proteins by NMR spectroscopy. J Biomol NMR 75:71–82. https://doi.org/10.1007/S10858-020-00356-4/TABLES/3

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang TY, Chi LM, Chien KY (2018) Size-exclusion chromatography using reverse-phase columns for protein separation. J Chromatogr A. https://doi.org/10.1016/j.chroma.2018.08.020

Article  PubMed  PubMed Central  Google Scholar 

Jia M, Mozziconacci O, Abend A et al (2022) Multi-dimensional plug-and-play liquid chromatography-native ion mobility mass spectrometry method for the analysis of biotherapeutics. Int J Mass Spectrom 471:116725. https://doi.org/10.1016/J.IJMS.2021.116725

Article  CAS  Google Scholar 

Knudsen LB, Lau J (2019) The discovery and development of liraglutide and semaglutide. Front Endocrinol (Lausanne). https://doi.org/10.3389/fendo.2019.00155

Article  PubMed  Google Scholar 

Kurtzhals P, Østergaard S, Nishimura E, Kjeldsen T (2023) Derivatization with fatty acids in peptide and protein drug discovery. Nat Rev Drug Discov 22:59–80. https://doi.org/10.1038/s41573-022-00529-w

Article  CAS  PubMed  Google Scholar 

Kyriakopoulos S, Kontoravdi C (2013) Analysis of the landscape of biologically-derived pharmaceuticals in Europe: dominant production systems, molecule types on the rise and approval trends. Eur J Pharm Sci 48:428–441. https://doi.org/10.1016/j.ejps.2012.11.016

Article  CAS  PubMed  Google Scholar 

Lau JL, Dunn MK (2018) Therapeutic peptides: historical perspectives, current development trends, and future directions. Bioorg Med Chem 26:2700–2707. https://doi.org/10.1016/J.BMC.2017.06.052

Article  CAS  PubMed  Google Scholar 

Leginus J (2014) CENTER FOR DRUG EVALUATION AND RESEARCH. Chemistry Review NDA 206321 SaxendaTM (Liraglutide [rDNA origin] Injection) for the division of metabolism and endocrinology products CHEMISTRY REVIEW #1. https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/206321Orig1s000ChemR.pdf

Li J, Merkler DJ, Han Q (2023) Editorial: aromatic amino acid metabolism–volume II. Front Mol Biosci. https://doi.org/10.3389/fmolb.2022.1122151

Article  PubMed  PubMed Central  Google Scholar 

Lou W, Stimple SD, Desai AA et al (2021) Directed evolution of conformation-specific antibodies for sensitive detection of polypeptide aggregates in therapeutic drug formulations. Biotechnol Bioeng 118:797–808. https://doi.org/10.1002/BIT.27610

Article  CAS  PubMed  Google Scholar 

Luo Q, Joubert MK, Stevenson R et al (2011) Chemical modifications in therapeutic protein aggregates generated under different stress conditions. J Biol Chem 286:25134–25144. https://doi.org/10.1074/JBC.M110.160440

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mathieu Verbeken SVD (2012) Purity profiling of peptide drugs. J Bioanal Biomed. https://doi.org/10.4172/1948-593X.S6-003

Article  Google Scholar 

Meier JJ (2012) GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus. Nat Rev Endocrinol 8:728–742. https://doi.org/10.1038/nrendo.2012.140

Article  CAS  PubMed  Google Scholar 

Molineau J, Hideux M, Hennig P et al (2022) Analysis of short-chain bioactive peptides by unified chromatography-electrospray ionization mass spectrometry. Part II. Comparison to reversed-phase ultra-high performance liquid chromatography. J Chromatogr A. https://doi.org/10.1016/j.chroma.2021.462771

Article  PubMed  Google Scholar 

Müller TD, Blüher M, Tschöp MH, DiMarchi RD (2022) Anti-obesity drug discovery: advances and challenges. Nat Rev Drug Discov 21:201–223. https://doi.org/10.1038/s41573-021-00337-8

Article  CAS  PubMed  Google Scholar 

Pan C, Liu F, Motto M (2011) Identification of pharmaceutical impurities in formulated dosage forms. J Pharm Sci 100:1228

Article  CAS  PubMed  Google Scholar 

Patel S, Vyas VK, Mehta PJ (2023) A review on forced degradation strategies to establish the stability of therapeutic peptide formulations. Int J Pept Res Ther 29:22. https://doi.org/10.1007/s10989-023-10492-8

Article  CAS  Google Scholar 

Pérez-Robles R, Salmerón-García A, Hermosilla J et al (2023) Comprehensive physicochemical characterization of a peptide-based medicine: teduglutide (Revestive®) structural description and stress testing. Eur J Pharm Biopharm 184:103–115. https://doi.org/10.1016/j.ejpb.2023.01.001

Article  CAS  PubMed